Home > Category > Chiral Reagent > (13bR)-5,7&4,7-Dihydro-2,8-bis((tert-butyldimethylsilyl)oxy)-3H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene

(13bR)-5,7&4,7-Dihydro-2,8-bis((tert-butyldimethylsilyl)oxy)-3H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene

Daicel≥95%,99%e.e.

Catalog No：201276-100MG CAS No.：NA MDLNo： Brand:Daicel purity：≥95%,99%e.e. 特性： Purpose:

Share

Size	Availability	Price(USD)
100MG	请咨询	$2885.00

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	(13bR)-5,7&4,7-Dihydro-2,8-bis((tert-butyldimethylsilyl)oxy)-3H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene
CAS	NA
Formula	C₃₉H₄₈O₂Si₂

Related literature

Sorry, there is no relevant literature

Related

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

2409652-68-0 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

History

(13bR)-5,7&4,7-Dihydro-2,8-bis((tert-butyldimethylsilyl)oxy)-3H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene

(13bR)-5,7&4,7-Dihydro-2,8-bis((tert-butyldimethylsilyl)oxy)-3H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene

NA ≥95%,99%e.e.

Bepridil hydrochloride hydrate

Bepridil hydrochloride hydrate

Costar 6 Well Clear, Flat Bottom, Ultra Low Attachment Multiple Well Plates with Lid, Sterile, Individually Wrapped, 24/Case

Costar 6 Well Clear, Flat Bottom, Ultra Low Attachment Multiple Well Plates with Lid, Sterile, Individually Wrapped, 24/Case

(R)-4,12-Bis(1,1-bis(3,5-dimethylphenyl)phosphine)-[2.2]paracyclophane

(R)-4,12-Bis(1,1-bis(3,5-dimethylphenyl)phosphine)-[2.2]paracyclophane

325168-89-6 ≥98%,99%e.e.

Diflufenican

CR-1-31-B

DavePhos

213697-53-1 ≥98%,-

ML417